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INTRODUCTION
According to the psychobiological model of temperament 
and character1 the human temperament can be divided into 
four different independent dimensions and character into 
three different dimensions. The temperamental features are: 1) 
the behavior in relation to new or pleasure-producing stimuli 
(novelty seeking, NS), 2) behavioral inhibition in relation to 
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issues which may lead to negative consequences (harm avoid-
ance, HA), 3) continuing of behavior that has earlier been suc-
cessful in the hope of reward (reward dependence, RD), and 
the tendency to maintain certain behavior despite frustration 
(persistence, P).1 These temperament dimensions are suggest-
ed to be connected with central neurotransmitter circuits in 
the central nervous system: dopamine (novelty seeking), se-
rotonin (harm avoidance) and norepinephrine (reward de-
pendence).2 The three dimensions of character mature in adult-
hood and influence personal and social effectiveness by insight 
learning about self-concepts. Self-concepts vary according to 
the extent to which a person identifies the self as 1) an autono-
mous individual (self-directedness, SD), 2) an integral part of 
humanity (cooperativeness, C), and 3) an integral part of the 
universe as a whole (self-transcendence, ST).1
The Temperament and Character Inventory (TCI) has been 
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used in general population studies and in studies including 
patients with major depressive disorder (MDD) to assess how 
different temperament dimensions are associated with this 
disorder.1 HA has reportedly been higher in MDD patients 
than in general population3-9 and has been state dependent 
in MDD.5,6 HA has also been associated with depressive symp-
toms in general population.10-12 HA, RD and NS have been 
found to have trait-like characteristics that are related to the 
familial occurrence of depression.4 High HA has been report-
ed to predict poor treatment outcome.8,13-15
HA also seems to have a trait-like characteristic, reflecting 
genetic susceptibility in depression prone subjects.4,16 It seems 
that HA is both a state- and trait-dependent variable in MDD.17 
However, one study using the Hospital Anxiety and Depres-
sion Scale (HAD), which excludes somatic symptoms, found 
no association between HA and MDD.18 This finding may 
suggest that HA is connected specifically to the somatic com-
ponent of MDD. The contribution of other temperament di-
mensions in MDD is somewhat controversial or limited. Low 
RD may be associated with MDD and depressive symptoms in 
general population,4 but the results are unequivocal.10,19 NS 
seems to be state dependent in MDD and altogether lower in 
MDD patients.4,11 However, high NS has been associated with 
history of suicide attempts in general population.20 In one 
study P was a state marker in depression.17 
In a study by Grucza et al.20 different combinations of tem-
perament dimensions were associated with different depres-
sive symptoms. It has been proposed that the symptoms of 
MDD consist of clusters, which are linked to distinct genetic 
mechanisms which when combined in one individual, can 
lead to a diagnosable psychopathology.21 Suzuki et al.22 pro-
posed a three-factor model of the MADRS to differentiate the 
vegetative symptoms (somatic symptoms) observed in a pa-
tient group. This three-factor model has been used in some 
studies with MDD patient samples.23-25 It has been proposed 
that the vegetative symptoms are connected to enhanced ex-
pression of 5HT2A receptors.25 We found no studies address-
ing the association of temperament and vegetative symptoms 
of MDD. The present study analyzes if temperament profiles 
in association with vegetative symptoms explain the antide-
pressant treatment response in MDD patients and if the se-
verity of depression is associated with current temperament 
clusters. 
METHODS 
A hundred Finnish outpatients were recruited from sec-
ondary outpatient services, primary health care and by news-
paper advertisements during the years 2002–2006 in the area 
of Tampere in southern Finland. The study was approved by 
the local Human Subjects Review Committee and subjects 
participated having given informed, voluntary, written con-
sent. The recruitment resulted in 41 female and 59 male out-
patients, aged 19–72 yrs (mean 40.7 years, SD±14.0). Patients 
met the criteria for major depressive episode according to 
the Diagnostic and Statistical Manual of Mental Disorders, 
fourth edition (DSM-IV). All patients were diagnosed by a 
psychiatrist and the severity of their depression was evaluat-
ed with the Montgomery-Åsberg Depression Rating Scale 
(MADRS). Those patients who scored 20 or higher at base-
line MADRS were included in the study. Patients with severe 
somatic illness or medication affecting their mood, other sig-
nificant psychiatric disorders (bipolar illness, psychosis or 
severe personality disorders) or patients with alcohol or sub-
stance abuse were excluded from the study. Eighty-six patients 
completed the entire study according to the protocol and were 
included in the final analysis.26 Study data was collected on 
three occasions. At the first visit basic sociodemographic data 
was collected: gender, age, marital status, education, workplace 
before the sick leave, somatic illnesses and their medications, 
other psychiatric disorders, and possible use of psychotrophic 
medications. The baseline MADRS form was scored and the 
patients completed the temperament section of the TCI ques-
tionnaire to assess the temperament profile.1 All patients were 
prescribed either citalopram, fluoxetine or paroxetine. Anx-
iolytics and sedative hypnotics as adjuvant treatment and oth-
er medication for concomitant general medical conditions 
were allowed. At the second visit, three weeks after initiation 
of treatment, patients’ adherence to treatment and the dosage 
of the medications were checked. Compliance was evaluated 
by a medication diary kept by the patient. Treatment compli-
ance was deemed sufficient if the patient had taken the medi-
cation on at least 80% of the days in the study period. At the 
third visit, six weeks after the initiation, patients’ adherence 
was monitored again and the MADRS and TCI forms were 
completed again (endpoint data). In the case of possible drop-
outs the necessary patient information on the reasons for 
dropout was also collected. The temperament profiles were 
determined from the baseline TCI data. The vegetative symp-
toms were assessed as the sum of questions three to five in the 
MADRS.22 These are impaired sleep, impaired appetite, and 
inner tension. 
Statistical methods
A two-step cluster analysis was used for the definition of the 
patient’s temperament profile. In our cluster model, we decid-
ed to use three temperament dimensions, NS, HA and RD 
with their baseline scores. In the statistical analysis the pa-
tients were divided into three clusters. 
The differences in continuous variables (MADRS total score, 
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MADRS factor scores and age) between the clusters were cal-
culated with ANOVA. The difference in MADRS change be-
tween low and high vegetative symptom groups was analyzed 
with t-test. Differences between grouping variables were cal-
culated with χ2-statistics. Non-parametric tests were used in 
comparisons in ordinal variables between different clusters 
(used medications, patient compliance). Pearson’s correlation 
coefficients were calculated between MADRS total score and 
vegetative symptom score, both at baseline and endpoint.
In the multivariate analysis all variables included in the 
study and likely to have an impact on either depression severi-
ty or treatment response were used in the models. The effect of 
background variables on clusters was analyzed with a multi-
nominal logistic regression model. Gender, age, severity of 
depression, antidepressant taken and dose, subjective adher-
ence to treatment, and earlier depression episode were used as 
explanatory variables. A linear regression model (ANCOVA) 
was used for testing the effects of temperament clusters and 
other variables on MADRS endpoint scores. The first model 
included temperament clusters and age, and the second model 
temperament clusters, age and the MADRS vegetative symp-
toms (questions 3–5) at baseline as explanatory variables. All 
analyses were performed with SPSS for Windows software 
(version 17.0).
RESULTS
The cluster analysis resulted in the following clusters: LNS/
HHA/LRD, INS/HHA/HRD and HNS/LHA/(HRD) with H 
indicating high level, L low level and I intermediate level on 
the temperament dimensions. In the third cluster RD did not 
reach statistical significance in the clustering model. In the 
first cluster we discovered the most robust slope in the NS 
and HA at baseline. In the second cluster there were elevated 
points in HA. The results of the cluster analysis and MADRS 
scores in each cluster are presented in Table 1.
There were no differences in the distributions of gender 
between the clusters (p=0.23, chi-square test). The patients in 
cluster 1 were older than in other clusters (age mean±SD, 
cluster 1=45.9±11.4, cluster 2=37.4±14.4, cluster 3=38.2±15.3; 
p=0.03, ANOVA). There was no difference between the clus-
ters in the dosages of the medications taken in weeks one to 
three (p=0.48, Kruskal Wallis test), nor in compliance to treat-
ment (p=0.69). Gender, severity of depression, antidepres-
sant taken and dose, adherence to treatment, and earlier de-
pression episode had no effect on the clusters in the multi-
nominal regression model. Age of the patients had a marginal 
effect on clusters (p=0.051) in the multinominal regression 
model.
The correlations between MADRS vegetative symptom 
score with MADRS total score were at baseline 0.73, (p<0.001) 
and at endpoint 0.76, (p<0.001). The MADRS vegetative 
symptom score at baseline had a moderate correlation with 
MADRS endpoint scores (r=0.38, p<0.001), and a non-signifi-
cant correlation with MADRS score change (r=0.13, p=0.26). 
We also analyzed the MADRS score change between patients 
with low (1–7, n=50) and high (8 or more, n=48) vegetative 
symptoms. The difference was close to significant [MADRS 
Table 1. Results of the cluster analysis. All scores except response percentages are indicated as mean±SD
Cluster LNS/HHA/LRD, N=33 INS/HHA/HRD, N=35 HNS/LHA/(HRD), N=30
TCI baseline score
NS 13.9±5.2 19.6±7.1 25.7±4.9
HA 26.8±6.1 27.2±3.6 16.0±4.2
RD 11.8±2.2 18.2±2.5 16.6±3.6
Baseline MADRS* 28.3±6.1 27.3±5.7 25.0±4.4
Factor 1 (dysphoria) 8.5±2.6 7.8±2.2 7.4±1.4
Factor 2 (retardation) 11.7±2.2 12.1±2.7 11.0±2.9
Factor 3 (vegetative symptoms) 7.8±3.1 7.4±2.8 6.4±2.7
Endpoint MADRS** 14.1±9.1 13.5±8.3 8.3±5.5
Factor 1 (dysphoria) 3.7±3.2 3.9±2.7 2.5±1.9
Factor 2 (retardation)***** 6.3±4.5 6.0±3.7 3.4±3.0
Factor 3 (vegetative symptoms) 3.5±2.3 3.7±2.9 2.4±1.9
MADRS score change*** 14.2±7.4 14.3±8.0 16.7±6.0
Response (percentage decline in MADRS)**** 51.6% 51.9% 66.7%
*p=0.05 between groups (ANOVA), **p=0.01 between groups (ANOVA), ***p=0.36 between groups (ANOVA), ****p=0.04 between groups 
(ANOVA), *****p=0.01 between groups (ANOVA). TCI: Temperament and Character Inventory, MADRS: Montgomery-Åsberg Depression 
Rating Scale, NS: novelty seeking, HA: harm avoidance, RD: reward dependence, with H indicating high level, L low level and I intermediate 
level on the temperament dimensions
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change, mean (±SD), low symptoms=13.5 (±5.5), high symp-
toms=16.6 (±8.5), p=0.052, t-test]. There were no differences 
in the MADRS vegetative symptom score at baseline or at end-
point between the different clusters (p=0.17, baseline; p=0.14, 
endpoint, ANOVA). There was a non-significant correlation 
between baseline MADRS dysphoria symptoms and MADRS 
score change (r=0.17, p=0.11). MADRS endpoint scores were 
used as the outcome variable in two linear regression models. 
In the first model age and temperament clusters were used as 
explaining variables. This model explained 10% of the vari-
ance in the MADRS endpoint scores (p=0.04; power 0.69). 
The clusters explained 9% (p=0.02), and age explained 1% 
(p=0.36). In the second model, baseline MADRS vegetative 
symptoms, age and temperament clusters were used as ex-
planatory variables. This model explained 20% of the variance 
in the MADRS endpoint scores (p=0.001; power 0.96 for the 
complete model). In this model the baseline vegetative symp-
toms explained 12% (p=0.001), age 0.2% (p=0.70) and tem-
perament clusters 5% (p=0.12). Using the delta scores of 
MADRS as an outcome variable, and age and temperament 
clusters as explanatory variables (first model), and vegetative 
symptoms, age and temperament clusters as explanatory vari-
ables (second model) resulted in non-significant models (first 
model: ηp2=0.085, p=0.061, power=0.61; second model: ηp2= 
0.096, p=0.087, power=0.60).
DISCUSSION
Our main hypothesis was that temperament clusters in pa-
tients with MDD explain the treatment response. In practice 
this means that different temperament profiles could func-
tion as a classifying factor and that MDD patients could be di-
vided into different groups with different outcomes for anti-
depressant treatment. In our study we used primarily the MA-
DRS endpoint scores as an outcome variable in the multi-
variate analyses. Using the delta scores of MADRS as an out-
come variable resulted in non-significant models although 
there was a trend towards a better response in patients with 
high vegetative symptoms. The present results suggest that 
the combined effect of vegetative symptoms and temperament 
clusters is important in relation to the depression treatment 
outcome when measured as post-treatment symptoms. How-
ever, these factors showed a non-significant effect when pre-
dicting the change in depression scores during treatment. This 
finding may be due to both the temperament clusters and pre-
treatment vegetative symptoms representing depressive traits 
less connected with the magnitude of symptom alleviation 
during treatment.
The approach of using TCI temperament clusters for pre-
dicting the response to antidepressant treatment in MDD pa-
tients is novel. In several studies individual dimensions of tem-
perament have been used as precursors. Two earlier studies 
with general population samples have used combinations of 
high or low temperament traits for predicting different clini-
cal features, but in these studies no cluster analysis method 
was used in classifying the temperament traits.18,20 This study 
did not include the character dimensions of the TCI (SD, C, 
ST) in the explanatory model. Adding the character traits to 
the predictors in the statistical model might have increased 
its predictive value regarding antidepressant response, since 
many studies have demonstrated that SD exhibits a state/trait 
marker in depression.9,27,28 
There were some limitations concerning our patient sam-
ple and study setting. In contrast to some earlier studies, our 
patient sample comprised solely outpatients. This may have 
resulted in lower intensity of symptoms as reflected by the 
MADRS scores. Temperament profiles could have had more 
explanatory power if the patient sample had included inpa-
tients with more severe depression. The patients were deemed 
compliant with medication if they took the prescribed medica-
tion at least 80% of the time, which can be regarded as a mod-
erate level of treatment compliance, and the data were col-
lected from patient reports, which in some cases may produce 
unreliable results. Nor did the patients receive any specific 
psychological treatment during the study, but were treated in 
a standard secondary outpatient setting.
As the relationship between temperament and vegetative 
symptoms of depression has not previously been studied, a 
post-hoc analysis with vegetative symptoms was performed 
in this study. This was done by separating the vegetative symp-
toms from the other symptoms of depression (dysphoria and 
retardation) which was based on the study by Suzuki et al.22 
It has been proposed that the vegetative symptoms are con-
nected to enhanced expression of 5-HT2A receptors.25
To assess patients’ temperament profiles we used Cloninger’s 
TCI, which has been widely used, validated and shown to be 
reliable in studies on general population and MDD patients.1 
Temperament profiles were determined by clustering the dis-
tributions in the three temperament dimensions. Due to the 
limited sample size, the number of clusters was determined 
as three in the analysis to yield groups of reasonable size. The 
clustering method was able to differentiate between the three 
combinations of temperament traits, although in the third 
cluster the difference on the dimension RD did not reach sta-
tistical significance. It has been suggested that high RD corre-
lates negatively with depressive symptoms, but the evidence 
is contradictory.3,4,9,10 The clusters differed on the dimension 
NS as it was low in cluster one, intermediate in cluster two and 
high in cluster three. The third cluster (HNS/LHA/HRD) prob-
ably reflects more impulsive depression, and diverges substan-
22  Psychiatry Investig 2014;11:18-23
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tially from the typical temperament profile of an MDD patient, 
and in this study from the other two temperament clusters. 
This may explain why this subgroup of patients recovered bet-
ter from the retardation symptoms than did the other patients. 
In addition, this group showed a higher percentage of MADRS 
changes. This difference in response could be due to the pre-
dictive effect of HA on MDD remission shown in our earlier 
report.29 In the first cluster we discovered the most distinct 
sloping in the distribution of the NS and HA dimensions at 
baseline. According to earlier reports the subgroup in this 
cluster has an increased risk for MDD and their depression is 
more disease-like.4-6,9 NS has been negatively associated with 
depressive mood state and tends to be at a low level in MDD 
patients.4 The clusters might thus reflect an underlying factor 
explaining clinically different symptoms profiles and course 
of depression.
In our study the temperament clusters were associated with 
both baseline and endpoint depressive symptoms and with 
the treatment response. The findings suggested that depression 
was most severe and difficult to treat in cluster one patients. 
In clusters one and two, in which HA scores were high, the re-
sponse in percentage decline of MADRS scores was lower than 
in cluster three. These findings concur with those of earlier 
studies on the association between HA and depression.4,5,7-9,15,30 
Although the depression vegetative symptom score is only 
a subscale of MADRS, it may be considered a separate dimen-
sion in depression symptomatology.22 MADRS total scores 
and vegetative symptoms showed a strong correlation at both 
baseline and endpoint. However, the correlation between 
MADRS endpoint total score and baseline vegetative symp-
tom score was much lower, suggesting that the vegetative 
symptoms are a separate entity within depressive symptom-
atology.22 Therefore we considered it justified to study the im-
pact of baseline vegetative symptoms on total symptoms at 
endpoint.
In the linear regression models our aim was to predict the 
treatment response in MDD patients. The first model was de-
signed to reveal the impact of temperament clusters on treat-
ment outcome. When patient’s age was also taken into ac-
count as an explanatory variable, the temperament clusters 
had only modest explanatory power. Age as such did not func-
tion as an explaining variable in this model at a significant 
level. In the second model we wanted to ascertain if there 
was an interaction with temperament clusters and vegetative 
symptoms of MDD. Therefore we added the vegetative symp-
tom scores to the model as an explanatory variable. In this 
model, the vegetative symptoms explained about twice as 
much as the clusters of the variance of endpoint MADRS 
scores. However, the whole model explained as much as one 
fifth of the variance in response to SSRI treatment. The role 
of the interaction between temperament clusters and vegeta-
tive symptoms on treatment result has to be interpreted cau-
tiously, as the impact of clusters on treatment response in the 
final model was marginal. It seems that the vegetative symp-
toms of depression, in addition to a certain temperament pro-
file, is a marked predictor for antidepressive treatment out-
come. It is, however, possible that the vegetative symptoms 
alone have a more marked impact in both severity and re-
sponse of depression compared to temperament. Even though 
the differences between the clusters in depression severity 
were marginal, our findings suggest an association between 
skewed temperament profile and severity of MDD. It is pos-
sible that the temperament profile can function as a predis-
posing factor to depression or have an impact on the clinical 
profile and course of depression. 
In conclusion our study showed that MDD patients could 
be divided into different temperament clusters with different 
severity and outcomes of antidepressant treatment. The vege-
tative symptoms of depression combined with temperament 
profiles and age predicted antidepressant treatment response. 
The effect of the temperament profile alone was modest but, 
combined with vegetative symptoms of depression their ex-
planatory power was more marked, suggesting that there 
could be an association between these two in the biological 
basis of MDD. 
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